Related Experiment Video
Updated: May 14, 2026
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
[Neonatal sepsis: new preventive strategies]
M Stronati1, L Bollani, R Maragliano
1Dipartimento di Neonatologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italia.
Minerva Pediatrica
|February 21, 2013
Summary
Neonatal sepsis remains a significant threat, causing over a million deaths annually. Promising prevention strategies include lactoferrin, early risk identification, heparin for catheter care, and antifungal agents, while certain immunoglobulins show no benefit.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Context:
- Neonatal infections cause over 1 million deaths globally each year.
- Incidence rates range from 0.3-3% in nurseries to 7-24.5% in Neonatal Intensive Care Units (NICUs), reaching 40% in extremely preterm infants.
- Sepsis accounts for 45-55% of all neonatal infections, representing a severe clinical challenge.
Purpose:
- To review current effective practices for reducing neonatal infections in NICUs.
- To explore novel and promising strategies for preventing nosocomial sepsis in hospitalized newborns.
- To evaluate the efficacy of emerging preventative measures against neonatal infections.
Summary:
- Established practices like hand hygiene, central venous catheter (CVC) management, accurate diagnostics, and judicious antibiotic use have reduced infection rates.
- New strategies under investigation include lactoferrin administration, early risk identification using markers like mannose-binding lectin, heparin for CVC-related infections, and antifungal agents for fungal sepsis prevention.
- Recent research indicates that specific immunoglobulins targeting staphylococcal antigens are ineffective in preventing neonatal sepsis.
Impact:
- Despite implemented practices, nosocomial infections persist, contributing to high mortality and morbidity in hospitalized neonates, particularly preterm infants.
- Continued research into novel prevention strategies is crucial for further reducing the burden of neonatal sepsis in NICUs.
- Effective implementation of these strategies can significantly improve outcomes for vulnerable newborns.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...